"The U.S. Food and Drug Administration today cleared a new screening test that predicts a patient's risk of future coronary heart disease (CHD) events, such as heart attacks.
FDA cleared the test for use in all adults with no history of hear"...
Large doses can depress atrioventricular and intraventricular conduction and thereby produce serious arrhythmias.
Last reviewed on RxList: 3/31/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Papaverine Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.